Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Enters Into $1.5B Loan Facility

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said last week that it has entered into a 364-day unsecured term loan facility in the principal amount of $1.5 billion.

The company may use the proceeds of the loans to help fund the acquisition of Patheon, which is estimated to be approximately $7.2 billion in total. This includes repayment of Patheon's debt and transaction costs incurred in connection with the acquisition.

The debt facility was established between Thermo Fisher; Bank of America, acting as the administrative agent; the lenders party; and Merrill Lynch, Pierce, Fenner & Smith, who is the sole lead arranger and sole bookrunner, Thermo Fisher said in a document filed with the US Securities and Exchange Commission.

Thermo Fisher announced the Patheon deal in May. It is expected to close around the end of the third quarter of 2017, subject to customary closing conditions.

Also last week, Thermo Fisher priced an offering of $1.5 billion of senior notes, also to fund the acquisition of Patheon.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.